Similar articles

• [Various aspects of the pharmacokinetics of Celospor with special reference to its affinity to cerebrospinal fluid].

  Meyer-Brunot HG, Schenk C, Schmid K, Spring P, Theobald W, Wagner J. Meyer-Brunot HG, et al. Wien Med Wochenschr Suppl. 1975;27:6-12. Wien Med Wochenschr Suppl. 1975. PMID: 1064254 German. No abstract available.
• Lack of penetration of cephacetril into the cerebro-spinal fluid of patients without meningitis.

  Friedrich H, Pelz K, Hänsel-Friedrich G. Friedrich H, et al. Infection. 1979;7(1):41-4. doi: 10.1007/BF01640557. Infection. 1979. PMID: 422254
• Studies on serum and cerebrospinal fluid levels of cephacetrile in neonates.

  Windorfer A, Gasteiger U. Windorfer A, et al. Infection. 1977;5(4):242-7. doi: 10.1007/BF01640789. Infection. 1977. PMID: 598930
• Advances in understanding the pharmacology of agents used to treat bacterial meningitis.

  Spector R. Spector R. Pharmacology. 1990;41(3):113-8. doi: 10.1159/000138706. Pharmacology. 1990. PMID: 2277805 Review.
• Bacterial meningitis in adults. A community perspective.

  Harris LF. Harris LF. Ala Med. 1988 Oct;58(4):20-4, 26. Ala Med. 1988. PMID: 3055898 Review. No abstract available.